Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty

被引：0

作者：

Matsuda, S ^{[1
]}

Kondo, M ^{[1
]}

Mashima, T ^{[1
]}

Hoshino, S ^{[1
]}

Shinohara, N ^{[1
]}

Sumida, S ^{[1
]}

机构：

[1] Kyushu Univ Hosp, Dept Orthoped Surg, Higashi Ku, Fukuoka 8128582, Japan

来源：

ORTHOPEDICS | 2001年 / 24卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

The effect of recombinant human erythropoietin on autologous blood donation was investigated in 73 rheumatoid arthritis patients who underwent hip or knee arthroplasty. Autologous blood donation of 400 mL was successful with recombinant human erythropoietin (12,000 U per week), and no homologous blood was required. The mean period of blood collection was 33.8 days. Mean hemoglobin levels were 9.7 g/dL before treatment, 10.7 g/dL before surgery, and 10.2 g/dL after surgery. This study confirmed recombinant human erythropoietin is effective for enabling preoperative blood donation in rheumatoid arthritis patients.

引用

页码：41 / 44

页数：4

共 50 条

[11] Factors Associated With Increasing Length of Stay for Rheumatoid Arthritis Patients Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
Morse, Kyle W.
Heinz, Nicole K.
Abolade, Jeremy M.
Wright-Chisem, Joshua
Russell, Linda Alice
Zhang, Meng
Mirza, Serene
Pearce-Fisher, Diyu
Orange, Dana E.
Figgie, Mark P.
Sculco, Peter K.
Goodman, Susan M.
HSS JOURNAL, 2022, 18 (02) : 196 - 204
[12] Management of autologous blood donation in total hip arthroplasty
Möllmann, M
von dem Berge, MM
Gurlit, S
Fard, FT
Sibrowski, W
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2003, 30 (05) : 210 - 213
[13] ERYTHROPOIETIN AND AUTOLOGOUS BLOOD DONATION IN SURGICAL RHEUMATOID-ARTHRITIS PATIENTS WITH ANEMIA
MERCURIALI, F
GUALTIERI, G
INGHILLERI, G
BIFFI, E
VINCI, A
COLOTTI, MT
SINIGAGLIA, L
BAROSI, G
TRANSFUSION, 1993, 33 (09) : S28 - S28
[14] Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty
Melita Buljan
Damir Nemet
Branka Golubic-Cepulic
Goran Bicanic
Branko Tripkovic
Domagoj Delimar
International Orthopaedics, 2012, 36 : 703 - 709
[15] Recombinant human erythropoietin to assist autologous blood donation by patients with anemia
Cazzola, M
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (04): : 354 - 356
[16] Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty
Buljan, Melita
Nemet, Damir
Golubic-Cepulic, Branka
Bicanic, Goran
Tripkovic, Branko
Delimar, Domagoj
INTERNATIONAL ORTHOPAEDICS, 2012, 36 (04) : 703 - 709
[17] RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR AUTOLOGOUS BLOOD DONATION
NONOGUCHI, H
ABE, K
KOMATSU, F
LANCET, 1992, 339 (8807): : 1483 - 1483
[18] Risk Factors for Transfusion and Use of Tranexemic Acid in Patients with Rheumatoid Arthritis Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
Morse, Kyle
Abolade, Jeremy
Heinz, Nicole
Zhang, Meng
Russell, Linda
Mirza, Serene
Orange, Dana
Wright-Chisem, Joshua
Figgie, Mark
Sculco, Peter
Goodman, Susan
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[19] Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty
Voorn, V. M. A.
van der Hout, A.
So-Osman, C.
Vlieland, T. P. M. Vliet
Nelissen, R. G. H. H.
van den Akker-van Marle, M. E.
Dahan, A.
Marang-van de Mheen, P. J.
van Bodegom-Vos, L.
VOX SANGUINIS, 2016, 111 (03) : 219 - 225
[20] Autologous blood transfusion with recombinant erythropoietin treatment in anaemic patients with rheumatoid arthritis
Tanaka, N
Ito, K
Ishii, S
Yamazaki, I
CLINICAL RHEUMATOLOGY, 1999, 18 (04) : 293 - 298

← 1 2 3 4 5 →